Delivery Order SPE2DB20D2002-SPE2DB24FL86U
Award Date
9/11/24
Potential Completion Date
9/12/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 120 mg/mL injectable medication. The $1,671.20 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,671.20, is for the supply of Emgality 120 mg/ml injectable medication. It is a firm fixed-price contract and does not have any set-aside requirements. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,729.00 firm-fixed-price contract is for the supply of Emgality 120 mg/ml injectable medication, a treatment for certain neurological conditions. The contract has an ultimate completion date of February 20, 2025 and is not designated as a set-aside. AmerisourceBergen is the prime contractor, and there is no information provided about any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at up to $3,212.48, is for the delivery of Emgality 120 mg/ml injectable medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.50 Firm Fixed Price Delivery Order covers the supply of Emgality 120 mg/mL injectable medication, with a period of performance through December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Emgality 120 mg/ml injectable medication. The $2,563.62 contract has a completion date of March 28, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNJ16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,726.88 firm fixed price delivery order is for the supply of Emgality 120 mg/ml injectable medication. The contract has an ultimate completion date of October 30, 2024. This award is not designated as a set-aside contract. Amerisourcebergen maintains a $999,999,999...
This federal contract award (SPE2DB22D3016|SPE2DB25FAFN0) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,624.96, is for the delivery of Emgality 120 mg/ml injectable medication. This award is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026....
This federal contract award, with ID SPE2DB20D2104|SPE2DB22FQ70X, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,640.24 firm fixed-price delivery order is for the supply of Emgality 120 mg/ml injectable medication. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.09 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml injection medication. The contract has an ultimate completion date of September 25, 2023 and was awarded on September 22, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...